DV
Dividend Vision

BIB — ProShares Ultra Nasdaq Biotechnology

ProShares Ultra Nasdaq Biotechnology (BIB)

BIB pays a 0.03% distribution rate, quarterly, on a 0.95% expense ratio. Its Distribution Safety Score™ is 42 (Caution), giving a Safety-Adjusted Yield of 0.01%. Total return is 1364.6% over the past 16.4 years, 592.3 points ahead of SPY at 772.3%. Its deepest 1-year drawdown was 16.9%.

ProShares Ultra Nasdaq Biotechnology is an ETF that seeks leveraged exposure to Nasdaq-listed biotechnology and pharmaceutical companies, using derivatives and other instruments to amplify the index's movements. The fund has a modest current distribution rate and pays dividends quarterly, with an expense ratio of 0.95%. It appeals to investors seeking leveraged equity exposure to the biotech sector who understand the amplified volatility and risks that come with this strategy.

BIB key facts

Distribution Safety Score™
42 · Caution
Safety-Adjusted Yield
0.01%
Issuer
ProShares
Asset type
ETF
Asset class
Equity
Inception date
04/06/2010
Expense ratio
0.95%
Distribution rate
0.03%
Distribution frequency
Quarterly
Trailing yield
0.30%
Last close
$106.87
AUM
$81,229,566
Average volume
6200.0
Last dividend
$0.0070
Ex-dividend date
03/25/2026
Payment date
03/31/2026
Beta
1.13
P/E ratio
30.7407